In Stock ARA-290 10MG is a 10-milligram format of ARA-290, an erythropoietin derived peptide analogue designed to model tissue protective signaling without erythropoietic activity
LavION uses iontophoresis to support transdermal delivery of active compounds without injections
, ( )
This concentration allows for easy dose calculations while keeping injection volumes manageable
Thus, the reported myotendinous junction recovery [43] and restoration of full function might illustrate all possible particularities of the capability of the stable gastric pentadecapeptide BPC 157 therapyapplied alone, as native peptide therapy, effective in rat injury, and given intraperitoneally or in drinking water [1,3,4,9,32,33,34]
Improved range of motion at injury sites